-
CA-074 Me and the Lysosomal Gate to Cell Death
2026-08-18
Lysosomal membrane permeabilization is emerging as a decisive checkpoint in necroptosis and inflammatory injury. This thought-leadership guide explains how CA-074 Me, a cell-permeable cathepsin B inhibitor, can help translational researchers distinguish lysosomal protease activity from upstream pathway activation while designing more informative cell and animal studies.
-
Influenza Hemagglutinin (HA) Peptide Workflow
2026-08-18
Turn HA-tagged constructs into cleaner capture, elution, and interaction assays with a soluble competitive reagent. This guide connects routine immunoprecipitation with a cancer-metabolism study that used HA-tagged IDH1 to examine mutation-dependent biochemical regulation.
-
Trelagliptin, RUNX2, and Osteoblastic Differentiation
2026-08-17
The reference study identifies trelagliptin as a potential stimulator of osteoblastic differentiation in MC3T3-E1 cells, linking its effects to RUNX2 upregulation and AMPK activation. Its findings provide a mechanistic basis for considering DPP-4 inhibitor repurposing in osteoporosis, while remaining preclinical and requiring validation in primary cells and in vivo models.
-
Dabigatran Workflows for Coagulation Research
2026-08-17
Build reproducible thrombin inhibition assays with Dabigatran, from concentration scouting to orthogonal coagulation readouts. This guide connects Pradaxa pharmacology with cardio-cerebrovascular research while emphasizing matrix controls, solubility limitations, and practical troubleshooting.
-
L1023 Anti-Cancer Compound Library Workflow
2026-08-16
Build a reproducible cancer research workflow around 1,164 curated bioactive compounds, from plate preparation and pathway screening to biomarker-led validation. Use L1023 to compare phenotypic responses with mechanistic evidence, including PLAC1-focused assays and BRAF kinase inhibitor profiling.
-
Deferasirox in Nutrient-Stress Iron Research
2026-08-15
Deferasirox enables controlled manipulation of labile iron, mitochondrial ROS, and stress-sensitive cell death pathways in hematopoietic and cancer models. This guide connects its iron-chelation workflow with TCF25-driven lysosomal adaptation while emphasizing assay controls, dose selection, and interpretation limits.
-
SOAT1, Lipophagy, and PHMG Lung Fibrosis
2026-08-14
The reference study identifies sterol O-acyltransferase 1 (SOAT1) as a previously unrecognized driver of PHMG-induced pulmonary fibrosis by linking cholesterol ester accumulation in alveolar macrophages to defective lipophagy and foam-cell formation. Its preclinical avasimibe experiments support SOAT1 inhibition as a mechanistically grounded strategy, while also highlighting the need to distinguish membrane cholesterol changes from broader cellular lipid metabolism.
-
Angiotensin Peptides Enhance SARS-CoV-2 Spike Binding
2026-08-14
The reference study shows that naturally occurring angiotensin fragments can increase SARS-CoV-2 spike-protein binding to host receptors, with the strongest effects associated with specific N-terminal deletions and tyrosine modifications. These findings connect renin-angiotensin signaling pathway biology with receptor-binding mechanisms, while also highlighting that biochemical enhancement of binding is not equivalent to demonstrated changes in viral infection or disease severity.
-
Chronic Stress, Mitochondria, and MnTBAP
2026-08-13
The reference study links chronic unpredictable mild stress with depression-like behavior, impaired mitochondrial function, and neuroinflammation in the rat hippocampus and prefrontal cortex. Its use of intracerebroventricular MnTBAP as a mechanistic intervention suggests that mitochondrial redox dysfunction contributes to stress-related behavioral changes, while also highlighting important limits for causal interpretation and cross-model translation.
-
EGCG for Translational Research: From Redox to Rescue
2026-08-13
(-)-Epigallocatechin gallate (EGCG) offers translational researchers a chemically defined way to investigate interconnected redox, apoptosis, angiogenesis, viral replication, and tumorigenesis pathways. By comparing EGCG with complex food-derived matrices such as Tapuy lees—and by separating mechanistic hypotheses from demonstrated efficacy—research teams can build more rigorous, decision-ready workflows for cancer, infection, and neurodegeneration research.
-
Oleic Acid: A Causal Lipid Stress-Test
2026-08-12
Oleic Acid and C18:1(9Z) can do more than model lipid accumulation. This article presents a causal assay framework for separating fatty-acid injury, lipid remodeling, and pathway-specific rescue, anchored by a recent hepatic ischemia-reperfusion study.
-
MnTBAP Chloride: Mitochondrial ROS Workflow
2026-08-12
MnTBAP Chloride gives researchers a practical way to test whether mitochondrial superoxide contributes to oxidative injury, inflammation, or stress-related phenotypes. This workflow connects cell-based paraquat studies with ATP, cytokine, and behavioral endpoints in preclinical models while highlighting critical controls and interpretation limits.
-
Grazoprevir hydrate: HCV Assay Workflows
2026-08-11
Build genotype-aware HCV replication assays around Grazoprevir hydrate, with practical guidance for stock preparation, potency measurement, combination testing, and cytotoxicity controls. The workflow also connects bench findings to genotype 1 and 4 disease research, HIV/HCV coinfection therapy, and chronic kidney disease studies without confusing research concentrations with clinical dosing.
-
Estradiol, GPR30, and T-Cell Recovery After Shock
2026-08-11
The reference study shows that 17β-estradiol restores splenic CD4+ T-lymphocyte proliferation and cytokine production after hemorrhagic shock by reducing endoplasmic reticulum stress. Pharmacological evidence identifies ERα and GPR30, but not ERβ, as important components of this protective response, providing a useful framework for mechanistic estrogen signaling research.
-
Filipin III Maps Cholesterol Homeostasis in MASLD
2026-08-10
Filipin III provides a spatial approach to cholesterol detection in membranes that can complement molecular studies of MASLD. This article connects cholesterol-rich membrane microdomains with the CAV1–FXR–ABCG5/ABCG8 axis while defining practical assay controls and interpretation limits.